Terms: = Skin cancer AND PIK3R1, P27986, 5295, ENSG00000145675, p85-ALPHA, GRB1
20 results:
1. Pleomorphic dermal sarcoma of the scalp - A single-centre experience.
Mor E; Lonie S; Mitchell C; Henderson M; Webb A; Gyorki DE; Snow H
Surg Oncol; 2024 Feb; 52():102017. PubMed ID: 38091877
[TBL] [Abstract] [Full Text] [Related]
2. A somatic splice-site variant in pik3r1 in a patient with vascular overgrowth and low immunoglobulin levels: A case report.
Wilke MVMB; Schimmenti L; Lopour MQR; Tollefson MM; Klee EW
Mol Genet Genomic Med; 2023 Dec; 11(12):e2271. PubMed ID: 37641480
[TBL] [Abstract] [Full Text] [Related]
3. Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma.
Bastidas Torres AN; Melchers RC; Van Grieken L; Out-Luiting JJ; Mei H; Agaser C; Kuipers TB; Quint KD; Willemze R; Vermeer MH; Tensen CP
Haematologica; 2022 Jul; 107(7):1619-1632. PubMed ID: 34382383
[TBL] [Abstract] [Full Text] [Related]
4. Review of the European Society for Photodynamic Therapy (Euro-PDT) Annual Congress 2020.
Morton CA; Szeimies RM; Braathen LR
Eur J Dermatol; 2021 Feb; 31(1):17-21. PubMed ID: 33648910
[TBL] [Abstract] [Full Text] [Related]
5. Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK.
Tran KB; Kolekar S; Jabed A; Jaynes P; Shih JH; Wang Q; Flanagan JU; Rewcastle GW; Baguley BC; Shepherd PR
BMC Cancer; 2021 Feb; 21(1):136. PubMed ID: 33549048
[TBL] [Abstract] [Full Text] [Related]
6. Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy.
Olbryt M; Pigłowski W; Rajczykowski M; Pfeifer A; Student S; Fiszer-Kierzkowska A
Target Oncol; 2020 Feb; 15(1):101-113. PubMed ID: 31980996
[TBL] [Abstract] [Full Text] [Related]
7. The Small GTPase ARF6 Activates PI3K in Melanoma to Induce a Prometastatic State.
Yoo JH; Brady SW; Acosta-Alvarez L; Rogers A; Peng J; Sorensen LK; Wolff RK; Mleynek T; Shin D; Rich CP; Kircher DA; Bild A; Odelberg SJ; Li DY; Holmen SL; Grossmann AH
Cancer Res; 2019 Jun; 79(11):2892-2908. PubMed ID: 31048499
[TBL] [Abstract] [Full Text] [Related]
8. Several genotypes, one phenotype: PIK3CA/AKT1 mutation-negative hidradenoma papilliferum show genetic lesions in other components of the signalling network.
Pfarr N; Allgäuer M; Steiger K; Weichert W; Schirmacher P; Noske A; Stenzinger A
Pathology; 2019 Jun; 51(4):362-368. PubMed ID: 31010589
[TBL] [Abstract] [Full Text] [Related]
9. Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K
Pires da Silva I; Wang KYX; Wilmott JS; Holst J; Carlino MS; Park JJ; Quek C; Wongchenko M; Yan Y; Mann G; Johnson DB; McQuade JL; Rai R; Kefford RF; Rizos H; Scolyer RA; Yang JYH; Long GV; Menzies AM
Clin Cancer Res; 2019 Feb; 25(4):1272-1279. PubMed ID: 30630828
[TBL] [Abstract] [Full Text] [Related]
10. Multitrait genome association analysis identifies new susceptibility genes for human anthropometric variation in the GCAT cohort.
Galván-Femenía I; Obón-Santacana M; Piñeyro D; Guindo-Martinez M; Duran X; Carreras A; Pluvinet R; Velasco J; Ramos L; Aussó S; Mercader JM; Puig L; Perucho M; Torrents D; Moreno V; Sumoy L; de Cid R
J Med Genet; 2018 Nov; 55(11):765-778. PubMed ID: 30166351
[TBL] [Abstract] [Full Text] [Related]
11. An insight into the molecular genetics of a uveal melanoma patient cohort.
Kennedy S; Rice M; Toomey S; Horgan N; Hennessey BT; Larkin A
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1861-1868. PubMed ID: 30008023
[TBL] [Abstract] [Full Text] [Related]
12. Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type.
Zhou XA; Louissaint A; Wenzel A; Yang J; Martinez-Escala ME; Moy AP; Morgan EA; Paxton CN; Hong B; Andersen EF; Guitart J; Behdad A; Cerroni L; Weinstock DM; Choi J
J Invest Dermatol; 2018 Nov; 138(11):2365-2376. PubMed ID: 29857068
[TBL] [Abstract] [Full Text] [Related]
13. Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E).
Park J; Yang J; Wenzel AT; Ramachandran A; Lee WJ; Daniels JC; Kim J; Martinez-Escala E; Amankulor N; Pro B; Guitart J; Mendillo ML; Savas JN; Boggon TJ; Choi J
Blood; 2017 Sep; 130(12):1430-1440. PubMed ID: 28694326
[TBL] [Abstract] [Full Text] [Related]
14. Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics.
Cohen PR; Tomson BN; Elkin SK; Marchlik E; Carter JL; Kurzrock R
Oncotarget; 2016 Apr; 7(17):23454-67. PubMed ID: 26981779
[TBL] [Abstract] [Full Text] [Related]
15. A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma.
Walsh NM; Fleming KE; Hanly JG; Dakin Hache K; Doucette S; Ferrara G; Cerroni L
Hum Pathol; 2016 Jun; 52():190-6. PubMed ID: 26980039
[TBL] [Abstract] [Full Text] [Related]
16. High-throughput screening identified inherited genetic variations in the EGFR pathway contributing to skin toxicity of EGFR inhibitors.
Hasheminasab SM; Tzvetkov MV; Schumann C; Rüdiger S; Boeck S; Heinemann V; Kächele V; Steffens M; Scholl C; Hichert V; Seufferlein T; Brockmöller J; Stingl JC
Pharmacogenomics; 2015; 16(14):1605-19. PubMed ID: 26419366
[TBL] [Abstract] [Full Text] [Related]
17. Identification of the interaction network of hub genes for melanoma treated with vemurafenib based on microarray data.
Quan L; Wang Y; Liang J; Shi J; Zhang Y; Tao K
Tumori; 2015; 101(4):368-74. PubMed ID: 25983087
[TBL] [Abstract] [Full Text] [Related]
18. High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.
van den Hurk K; Balint B; Toomey S; O'Leary PC; Unwin L; Sheahan K; McDermott EW; Murphy I; van den Oord JJ; Rafferty M; FitzGerald DM; Moran J; Cummins R; MacEneaney O; Kay EW; O'Brien CP; Finn SP; Heffron CC; Murphy M; Yela R; Power DG; Regan PJ; McDermott CM; O'Keeffe A; Orosz Z; Donnellan PP; Crown JP; Hennessy BT; Gallagher WM
Melanoma Res; 2015 Jun; 25(3):189-99. PubMed ID: 25746038
[TBL] [Abstract] [Full Text] [Related]
19. Novel somatic mutations to PI3K pathway genes in metastatic melanoma.
Shull AY; Latham-Schwark A; Ramasamy P; Leskoske K; Oroian D; Birtwistle MR; Buckhaults PJ
PLoS One; 2012; 7(8):e43369. PubMed ID: 22912864
[TBL] [Abstract] [Full Text] [Related]
20. Atypical fibroxanthoma: a series of 25 cases.
Wollina U; Schönlebe J; Koch A; Haroske G
J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):943-6. PubMed ID: 20158588
[TBL] [Abstract] [Full Text] [Related]
